KJaeva, Biserka
Preferred name
KJaeva, Biserka
Official Name
KJaeva, Biserka
Main Affiliation
Email
biserka.kjaeva@medf.ukim.edu.mk
33 results
Now showing 1 - 10 of 33
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, BODY MASS INDEX AS A DETERMINANT OF OUTCOME OF TREATMENT WITH NON-INVASIVE VENTILATION IN PATIENTS WITH RESPIRATORY FAILURE DUE TO ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE(Macedonian Association of Anatomists and Morphologists, 2015-12); ; ; Arbutina SIntroduction: In the last two decades noninvasive ventilation (NIV) has become an integral part of the protocol for the treatment of patients with acute respiratory failure. Aim of the study: To assess the relationship between body mass index (BMI) and outcome of treatment with NIV in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Material and methods: A total of 52 patients, over the age of 40, hospitalized because of acute exacerbation of COPD and treated with NIV were prospectively recruited. The patients were divided into two groups: 1) successful NIV treatment group; 2) failed NIV treatment group. Results: There was no significant difference in distribution between the two patients groups in terms of sex and age. Compared to group 1, in the group 2, difference was observed in the values of GCS that were lower, and the PaCO2 and APACHE II scores were higher, but the difference between the two groups was not significant (p> 0.05). Significant difference was observed between the values of pH (p <0.05) and BMI (p <0.01). The majority of patients with NIV treatment failure were with BMI <22kg / m2. Conclusion: The degree of acidosis and BMI are factors of statistical significance for the outcome of NIV treatment. Further studies are needed to clarify the reasons for the association between NIV and low BMI. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, LEUKOTRIENE RECEPTOR ANTAGONISTS IN MANAGING SEVERE UNCONTROLLED ASTHMA(European Medical Group, 2017-08-03); ; ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, IL-33 in patients with severe uncontrolled allergic asthma(European Respiratory Society, 2017-09); ; ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease(ID-Design/Scientific foundation SPIROSKI, 2016-05-22); ; ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The rationality of the use of NIV in elderly patients with acute COPD exacerbation(European Respiratory Society, 2018-09-15); ; ; ; Jovanoski, Smilko - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Predictive Factors for the Effect of Treatment by Noninvasive Ventilation in Patients with Respiratory Failure as a Result of Acute Exacerbation of the Chronic Obstructive PulmonaryDisease(ID Design 2012/Scientific Foundation SPIROSKI, 2015-11-11); ; ; Jovanovska Janeva E.BACKGROUND: Noninvasive mechanical ventilation (NIV) applies ventilator support through the patient’s upper airway using a mask. AIM: The aim of the study is to define factors that will point out an increased risk of NIV failure in patients with exacerbation of Chronic Obstructive Pulmonary Disease (COPD). PATIENTS AND METHODS: Patients over the age of 40, treated with NIV, were prospectively recruited. After data processing, the patients were divided into two groups: 1) successful NIV treat-ment group; 2) failed NIV treatment group.RESULTS: On admission arterial pH and Glasgow coma scale (GCS) levels were lower (pH: p<0.05, GCS: p<0.05), and Acute Physiology and Chronic Health Evaluation II (APACHE) score and PaCO2were higher (p<0.05) in the NIV failure group. Arterial pH was lower (p<0.05) and PaCO2and respiratory rate were higher (p<0.05) after 1h, and arterial pH was lower (p<0.05) and PaCO2(p<0.05), respiratory and heart rate were higher (p<0.05) after 4h in the NIV failure group.CONCLUSION: Measurement and monitoring of certain parameters may be of value in terms of predicting the effectiveness of NIV treatment.IntroductionChronic Obstructive Pulmonary disease (COPD) is one of the commonest diseases in the world. It is an increasing international health problem with a projected third leading cause of mortality within the adult population[1]. Chronic obstructive pulmo-nary disease is a respiratory disorder largely caused by smoking, and is characterized by progressive, par-tially reversible airway obstruction and lung hyperinfla-tion, systemic manifestations, and increasing fre-quency and severity of exacerbations. An acute exac-erbation is defined as a sustained worsening of dysp-nea, cough or sputum production leading to an in-crease in the use of maintenance medications and/or supplementation with additional medications[2]. The management of the acute exacerbations of COPD accounts for a large proportion of the health care costs because of the need for prolonged hospitaliza-tions and increased rate of mortality[3]. An important event in the course of the disease is the shortening of the inspiratory time, leading to a decrease of the Total Lung Capacity (TLC) and increase of the respiratory rate. The management which aims to increase the TLC with subsequent increase in the alveolar ventila-tion, as well as the decrease of the respiratory rate, is expected to reverse the impaired respiratory physiolo-gy[4]. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Correlation between plasma levels of IL-33 and Vitamin D in patients with severe uncontrolled allergic asthma(European Respiratory Journal, 2017-09); ; ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Key Issues in the Management of Multi-Drug Resistant Tuberculosis: A Case Report(ID-Design/Scientific foundation SPIROSKI, 2018-07-20); ; ; Global tuberculosis (TB) epidemic is being driven to an increasing extent by the emergence and spread of drug-resistant strains of Mycobacterium tuberculosis complex (MTBC). We present a case of primary multidrug-resistant tuberculosis (MDR-TB), highlighting Macedonian MDR-TB management issues. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Analysis of Lymphocyte Immunological Reactivity in Patients with Pleural Effusions of Different Aetiology(ID Design 2012/Scientific Foundation SPIROSKI, 2016-03-15); - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of Disease(Scientific Foundation SPIROSKI, Skopje, 2016-05-22); ; ; ;